Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001223359-04-000002
Filing Date
2004-03-02
Accepted
2004-03-02 13:23:45
Documents
1
Period of Report
2004-02-27

Document Format Files

Seq Description Document Type Size
1 emk107.html 4  
1 emk107.xml 4 3197
  Complete submission text file 0001223359-04-000002.txt   4867
Mailing Address CN 5350 PRINCETON NJ 08543-5350
Business Address CN 5350 PRINCETON NJ 08543-5350 6094523600
PHARMACOPEIA INC (Issuer) CIK: 0001002388 (see all company filings)

EIN.: 330557266 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PHARMACOPEIA P O BOX 5350 PRINCETON NJ 08543-5350
Business Address
EMKJER MARK J (Reporting) CIK: 0001223359 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27188 | Film No.: 04641950